Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Porfirio Sanchez received a six-month jail term Friday for the 2023 deaths of Christian and Michelle Deaton in a crash ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss drugs. Set ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

The demand for semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA) commonly known under the brand names Ozempic and Wegovy, has surged in recent years, especially for weight loss.

today announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the glucagon-like peptide-1 receptor (GLP-1) agonist semaglutide administered ...